1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)" is currently closed and not accepting applications.
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) is sponsored by Centers for Disease Control and Prevention (CDC). This grant aims to support research into potential risk factors for ALS, which may include fall-related injuries.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Agency: Centers for Disease Control and Prevention - ERA Assistance Listings: 93. 061 -- Innovations in Applied Public Health Research Last Updated: May 13, 2026 View version history on Grants.
gov CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged.
Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such...
as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.
Public and state institutions of higher education Independent school districts Private institutions of higher education Special district governments Federally recognized Native American tribal governments Public and Indian housing authorities City or township governments Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Other Native American tribal organizations Additional Eligibility Information to be included in the NOFO.
Grantor contact information File name Description Last updated rfa-ts-26-165_rev10. pdf rfa-ts-26-165_rev10. pdf May 11, 2026 09:40 PM UTC Link to additional information Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofits, universities, state/local governments, and other research organizations. Confirm the full requirements in the official notice before applying.
The published deadline was June 10, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) is funded by Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articleHHS has obligated roughly half a percent of the FY2026 Teen Pregnancy Prevention appropriation with days left before September 30. Here is the full timeline, the replacement NOFO that closed in July, the August court ruling, and what grantees should be doing right now.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read article